Status:
COMPLETED
Investigating the Impact of Environmental Factors on the Transcriptomics Profile in Healthy Individuals
Lead Sponsor:
CENTOGENE GmbH Rostock
Conditions:
Healthy Volunteers
Eligibility:
All Genders
18+ years
Brief Summary
Changes in biology will be reflected by changes in the composition of Ribonucleic acid (RNA) in the blood. An example of that would be environmental changes, e.g. diet, acute illness, temperature. The...
Detailed Description
The project is aiming to evaluate the impact of environmental changes on the blood transcriptome and to assess the feasibility of different sample collection materials for this purpose. Transcriptome ...
Eligibility Criteria
Inclusion
- Voluntary, informed consent is obtained from the subject before enrollment in the study
- The subject is 18 years or older (≥18 years)
- Healthy participants, as declared by the subject
- Healthy status is defined by the absence of evidence of any active or chronic disease at the beginning of the study
- Available to participate for the planned duration of the study for which the screening is being done
Exclusion
- • The subject had any clinically significant disease
- Any clinically relevant history or the presence of e.g., respiratory, renal, hepatic, gastrointestinal, hematological, lymphatic, neurological, cardiovascular, psychiatric, etc. chronic disease
- Concomitant disease or condition that could interfere with, or treatment of which might interfere with, the conduct of the study, or that would, in the opinion of the investigator, pose an unacceptable risk to the subject in this study
- A condition in which repeated blood draws poses more than minimal risk for the subject such as hemophilia, other severe coagulation disorders or significantly impaired venous access
- In the opinion of the investigator, subject is at high risk of non-compliance and is unsuitable in any other way to participate in this study
- No informed consent obtained from the subject
Key Trial Info
Start Date :
May 9 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 29 2024
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT06040008
Start Date
May 9 2023
End Date
February 29 2024
Last Update
September 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centogene GmbH
Rostock, Mecklenburg-Vorpommern, Germany, 18055